ArticleWorld journal of surgical oncology2012

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study.

Chieh-Lin Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.